Maaike Biewenga

An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis

Romée J.A.L.M. Snijders, Anna Stoelinga, Tom J.G. Gevers et al. · Journal of Hepatology · 2023 · 75 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation

Aldo J. Montaño‐Loza, Vincenzo Ronca, Maryam Ebadi et al. · Journal of Hepatology · 2022 · 64 citations · Full text

Medicine, Immunology, Internal Medicine +16

Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis

Francesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak et al. · Journal of Hepatology · 2023 · 54 citations · Full text

Medicine, Immunology, Oncology +12

Role of age in presentation, response to therapy and outcome of autoimmune hepatitis

Martine A.M.C. Baven‐Pronk, Maaike Biewenga, Joanne J. van Silfhout et al. · Clinical and Translational Gastroenterology · 2018 · 39 citations · Full text

Medicine, Geriatric Medicine, Internal Medicine +13

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients

Maaike Biewenga, Monique K. van der Kooij, Michel W.J.M. Wouters et al. · Hepatology International · 2021 · 39 citations · Full text

Medicine, Immunology, Oncology +17